Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1999-8-3
pubmed:abstractText
In diabetes mellitus, enhanced activity of mesangial cell protein kinase C (PKC) may contribute to nephropathy. The purpose of this study was to determine whether high glucose alters mesangial cell diacylglycerol-sensitive PKC-alpha, -beta2, -delta, and -epsilon content, cellular distribution, and activity through polyol pathway activation. Primary cultured rat mesangial cells (passage 10) were growth-arrested in 0.5% fetal bovine serum and cultured in 5.6 mM glucose (NG) or 30 mM glucose (HG) for 48 h, with or without the aldose reductase inhibitor tolrestat or ARI-509. PKC isoform content in total cell lysates, or cytosol, membrane (Triton X-soluble), and particulate (sodium dodecyl sulfate-soluble) fractions was analyzed by immunoblotting, and band density in HG was expressed as a percentage of corresponding NG values. In HG at 48 h, increased total PKC-alpha (222 +/- 17% of NG, P < 0.001), -beta2 (209 +/- 12%, P < 0.001), and -epsilon (195 +/- 19%, P < 0.001) were observed. L-Glucose had no effect on total PKC isoform content. HG caused increased membrane- and particulate-associated PKC-alpha (257 +/- 87 and 327 +/- 66%, respectively, P < 0.05), membrane-associated PKC-delta (143 +/- 10%, P < 0.05), and membrane-associated PKC-epsilon (186 +/- 11%, P < 0.001), with no change in cytosol contents. The HG effects were not mimicked by L-glucose. In NG or HG, PKC-beta2 was not detected in the cytosol fraction, and membrane and particulate association were unchanged with phorbol ester stimulation. Confocal immunofluorescence imaging revealed that in HG, PKC-alpha, -delta, and -epsilon translocate to the nucleus and plasma membrane. Total PKC activity measured by in situ 32P-phosphorylation of the epidermal growth factor receptor substrate increased from 18 +/- 1 pmol/min per mg cell protein in NG to 33 +/- 3 pmol/min per mg cell protein in HG (P < 0.002 versus NG). In NG, tolrestat and ARI-509 exposure caused increased PKC activity, enhanced accumulation of total PKC-alpha and -beta2, with no change in total or fractional recovery of PKC-delta or -epsilon. In HG, tolrestat and ARI-509 prevented the increase in total PKC-epsilon and membrane-associated PKC-delta and -epsilon. It is concluded that within 48 h of HG, enhanced mesangial cell PKC activity is associated with accumulation and cellular redistribution of diacylglycerol-sensitive PKC isoforms, and that increased PKC-epsilon content and membrane-associated PKC-delta and -epsilon are dependent on polyol pathway activation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes, http://linkedlifedata.com/resource/pubmed/chemical/Naphthalenes, http://linkedlifedata.com/resource/pubmed/chemical/Polymers, http://linkedlifedata.com/resource/pubmed/chemical/Prkcd protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Prkce protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C-delta, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C-epsilon, http://linkedlifedata.com/resource/pubmed/chemical/Sorbitol, http://linkedlifedata.com/resource/pubmed/chemical/polyol, http://linkedlifedata.com/resource/pubmed/chemical/tolrestat
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1046-6673
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1193-203
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:10361857-Animals, pubmed-meshheading:10361857-Blotting, Western, pubmed-meshheading:10361857-Cattle, pubmed-meshheading:10361857-Cells, Cultured, pubmed-meshheading:10361857-Dose-Response Relationship, Drug, pubmed-meshheading:10361857-Drug Interactions, pubmed-meshheading:10361857-Enzyme Inhibitors, pubmed-meshheading:10361857-Glomerular Mesangium, pubmed-meshheading:10361857-Glucose, pubmed-meshheading:10361857-Isoenzymes, pubmed-meshheading:10361857-Male, pubmed-meshheading:10361857-Microscopy, Confocal, pubmed-meshheading:10361857-Naphthalenes, pubmed-meshheading:10361857-Polymers, pubmed-meshheading:10361857-Protein Kinase C, pubmed-meshheading:10361857-Protein Kinase C-delta, pubmed-meshheading:10361857-Protein Kinase C-epsilon, pubmed-meshheading:10361857-Rats, pubmed-meshheading:10361857-Rats, Sprague-Dawley, pubmed-meshheading:10361857-Reference Values, pubmed-meshheading:10361857-Sensitivity and Specificity, pubmed-meshheading:10361857-Sorbitol
pubmed:year
1999
pubmed:articleTitle
Effect of high glucose on mesangial cell protein kinase C-delta and -epsilon is polyol pathway-dependent.
pubmed:affiliation
Institute of Medical Science and Department of Medicine, University of Toronto, Ontario, Canada.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't